SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-006475
Filing Date
2021-03-22
Accepted
2021-03-19 20:28:33
Documents
3
Period of Report
2021-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 35115
2 ex10-1.htm EX-10.1 974
3 ex10-1_001.jpg GRAPHIC 134429
  Complete submission text file 0001493152-21-006475.txt   222643
Mailing Address 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE MA 02140 1 617 430 5222
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-187874 | Film No.: 21759603
SIC: 2834 Pharmaceutical Preparations